The introduction of biosimilars in the treatment of age-related macular degeneration (AMD) is raising concerns among physicians about cost-driven mandates and the autonomy to choose the best therapies ...

The overwhelming majority of people with the disease have dry AMD. With the dry form, parts of the macula — at the center of the retina, the light-sensitive tissue at the back of your eyes — become ...

Biotech company Neurotech Pharmaceuticals this month received regulatory approval for its treatment of a a neurodegenerative ...

Eye diseases often develop asymptomatically for many years. ICTER scientists have developed the f-ORG technique, which ...

The closing of the merger is expected to occur as soon as practicable, subject to the satisfaction or waiver of the remaining customary closing conditions. Following the closing of the merger, the ...

Myopia is a refractive error (blurred vision at a given distance) that affects about 30% of the world's population. This ...

UAB ophthalmology professor awarded prestigious award for vision research in diabetic retinopathy and macular degeneration ...

High levels of exposure to air pollution can increase the incidence of diabetic retinopathy and glaucoma, a recent study ...

Successful 2024 marked by significant clinical advancements across Oculis’ late-stage and highly differentiated clinical pipeline targeting ...

Age-related macular degeneration (AMD) AMD is a common eye condition that happens as you get older. It affects the macula, ...

NY Retina, a newly launched ophthalmology practice, is set to open March 20 in a newly purchased medical office building in ...